Login / Signup

Predictors and Outcomes of SGLT2 Inhibitor Discontinuation in a Real-World Population after Hospitalization for Heart Failure.

Masaki NakagaitoTeruhiko ImamuraRyuichi UshijimaMakiko NakamuraKoichiro Kinugawa
Published in: Biomedicines (2023)
Among patients who initiated SGLT2i during hospitalization for HF, lower serum albumin levels and higher doses of loop diuretic at index discharge were associated with the discontinuation of SGLT2i following index discharge. We should pay special attention to patients with such characteristics during the initiation of SGLT2i and during SGLT2i therapy.
Keyphrases
  • heart failure
  • acute heart failure
  • left ventricular
  • transcription factor
  • stem cells
  • adipose tissue
  • health insurance
  • metabolic syndrome
  • skeletal muscle
  • mesenchymal stem cells
  • weight loss
  • cell therapy